Review summary
Teaching objective: Evaluate lifelong episodic spells and chronic headache after an adolescent traumatic brain injury in an older adult: use EEG, brain MRI, ambulatory EEG, polysomnography, and a multiple sleep latency test to tell sleep attacks from focal seizures, recognize and withdraw medication overuse, choose non-sedating headache prevention and a wake-promoting agent, and keep both retrospective diagnoses, temporal lobe epilepsy and post-traumatic narcolepsy, graded as interpretation.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| About 1822 (early 1822) | Born into slavery in Dorchester County, Maryland; the year is uncertain. | CLM-0001, CLM-0002 |
| Mid-1830s, at about age 13 | Struck in the head by an iron weight thrown by an overseer. | CLM-0003 |
| From the mid-1830s onward | Headaches and sudden sleep spells with visions begin and persist through life. | CLM-0004 |
| 1844 | Married John Tubman. | CLM-0008 |
| 1849 | Escaped to Philadelphia. | CLM-0008 |
| 1869 | Married Nelson Davis in Auburn, New York. | CLM-0008 |
| Late 1890s (date unconfirmed) | Reported surgery in Boston for headaches. | CLM-0007 |
| March 10, 1913 | Died of pneumonia in Auburn, New York. | CLM-0009 |
| Retrospective proposals, 20th and 21st centuries | Temporal lobe epilepsy and post-traumatic narcolepsy proposed as explanations for the spells. | CLM-0005, CLM-0006 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Harriet Tubman was born into slavery in Dorchester County, Maryland, in early 1822 by the National Park Service account, and was named Araminta, or Minty, by her parents, Ben and Rit Ross; she was the fifth of nine children. No birth record survives; the year is an estimate. |
probable | The Life of Harriet Tubman (Harriet Tubman Underground Railroad Byway fact sheet) supports Harriet Ross Tubman Davis (b. circa 1822 - d. 1913), Biographical Series supports |
| D | Her birth year is uncertain: the Dictionary of Canadian Biography gives 1820 or 1821, while the National Park Service and the Maryland State Archives give about 1822. The case uses 1822 and records the alternative. |
confirmed | Thomas O. Ross, Araminta (Harriet Tubman). Dictionary of Canadian Biography, vol. 14 supports The Life of Harriet Tubman (Harriet Tubman Underground Railroad Byway fact sheet) supports Harriet Ross Tubman Davis (b. circa 1822 - d. 1913), Biographical Series supports |
| D | Hired out from the age of six, Tubman was struck in the head in her early teens, about age 13 in the mid-1830s, by an iron weight an overseer threw at another enslaved person at a village store; she was nearly killed, received little or no medical care, and was affected by the injury for the rest of her life. The documented injury that anchors the synthetic episode. The Maryland State Archives states that the blow broke her skull. |
confirmed | The Life of Harriet Tubman (Harriet Tubman Underground Railroad Byway fact sheet) supports Harriet Ross Tubman Davis (b. circa 1822 - d. 1913), Biographical Series supports Balmuth EA, Scammell TE. Harriet Tubman's Hypersomnia: Insights from Historical and Medical Perspectives. J Gen Intern Med. 2023;38(16):3621-3627 supports Thomas O. Ross, Araminta (Harriet Tubman). Dictionary of Canadian Biography, vol. 14 supports |
| D | After the injury Tubman had headaches and sudden spells of sleep that came on even in the middle of work or conversation, at frequent intervals, and ended abruptly after a few minutes, along with vivid dreams and visions; contemporaries described the spells into her old age. Lay descriptions; the modern label is uncertain. |
confirmed | Balmuth EA, Scammell TE. Harriet Tubman's Hypersomnia: Insights from Historical and Medical Perspectives. J Gen Intern Med. 2023;38(16):3621-3627 supports Thomas O. Ross, Araminta (Harriet Tubman). Dictionary of Canadian Biography, vol. 14 supports Harriet Ross Tubman Davis (b. circa 1822 - d. 1913), Biographical Series supports |
| R | Historians have proposed that the injury caused temporal lobe epilepsy, citing dreamlike trances in which she appeared conscious. A retrospective proposal; it stays off the active problem list. |
possible | Harriet Ross Tubman Davis (b. circa 1822 - d. 1913), Biographical Series supports |
| R | A 2023 review argued that temporal lobe epilepsy is unlikely, because she could be roused and no auras, automatisms, or post-ictal confusion were described, and proposed post-traumatic narcolepsy instead, while concluding that no definitive explanation is possible. A second retrospective proposal; it is linked to, not confirmed by, the synthetic diagnosis. |
possible | Balmuth EA, Scammell TE. Harriet Tubman's Hypersomnia: Insights from Historical and Medical Perspectives. J Gen Intern Med. 2023;38(16):3621-3627 supports |
| D | In her later years Tubman said that a Boston surgeon had opened her skull to relieve her headaches; historians place the operation in the late 1890s at Massachusetts General Hospital, but no record of it has been found. Her own account, published by her biographer Sarah Bradford in 1901; the date and procedure are unconfirmed. |
probable | Balmuth EA, Scammell TE. Harriet Tubman's Hypersomnia: Insights from Historical and Medical Perspectives. J Gen Intern Med. 2023;38(16):3621-3627 supports |
| D | Tubman married John Tubman in 1844, escaped to Philadelphia in 1849, guided about 70 people to freedom by 1860, served the Union army in South Carolina as a nurse, scout, and spy, and settled in Auburn, New York, where she married Nelson Davis in 1869. | confirmed | The Life of Harriet Tubman (Harriet Tubman Underground Railroad Byway fact sheet) supports |
| D | Tubman died of pneumonia in Auburn, New York, on March 10, 1913. Record the death as a fact without graphic detail. |
confirmed | The Life of Harriet Tubman (Harriet Tubman Underground Railroad Byway fact sheet) supports Thomas O. Ross, Araminta (Harriet Tubman). Dictionary of Canadian Biography, vol. 14 supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Recurrent sudden sleep episodes since an adolescent traumatic brain injury; narcolepsy without cataplexy due to a medical condition, provisional; historical cause retrospectively disputed | active | provisional | both_with_link | CLM-0004, CLM-0005, CLM-0006 |
| S | Chronic post-traumatic headache since an adolescent head injury | active | confirmed | both_with_link | CLM-0003, CLM-0004 |
| S | Medication-overuse headache from near-daily ibuprofen, resolved after withdrawal | resolved | confirmed | active | |
| S | Sequelae of a traumatic brain injury in adolescence, a skull fracture by historical account | active | confirmed | both_with_link | CLM-0003 |
| S | Acute viral gastroenteritis with mild dehydration and a prerenal creatinine rise while taking candesartan, resolved | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 1897-04-06 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1897-04-06 | Potassium [Moles/volume] in Serum or Plasma | 4.2 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1897-04-06 | Creatinine [Mass/volume] in Serum or Plasma | 0.84 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 1897-04-06 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1892)/1.73 sq M | 72 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1897-04-06 | Glucose [Mass/volume] in Serum or Plasma | 92 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1897-04-06 | Hemoglobin [Mass/volume] in Blood | 12.6 g/dL Reference 11.6-15 g/dL |
http://loinc.org · 718-7 |
| S | 1897-04-06 | Ferritin [Mass/volume] in Serum or Plasma | 88 ng/mL Reference 30-400 ng/mL |
http://loinc.org · 2276-4 |
| S | 1897-04-06 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 mIU/L Reference 0.45-4.5 mIU/L |
http://loinc.org · 3016-3 |
| S | 1897-04-06 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 410 pg/mL Reference 232-1245 pg/mL |
http://loinc.org · 2132-9 |
| S | 1897-04-06 | PROMIS sleep related impairment - version 1.0 Tscore | 68 | http://loinc.org · 77859-7 |
| S | 1897-04-06 | On how many days in the last 3 months did you have a headache, if headache lasted more than 1 day, count each day [PhenX] | 54 | http://loinc.org · 65380-8 |
| S | 1897-04-06 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | http://loinc.org · 44261-6 |
| S | 1897-04-06 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 2 | http://loinc.org · 70274-6 |
| S | 1897-04-06 | PC-PTSD-5 score [PC-PTSD-5] | 2 | http://loinc.org · 102017-1 |
| S | 1897-04-06 | Total score [MoCA] | 26 | http://loinc.org · 72172-0 |
| S | 1897-05-18 | Sodium [Moles/volume] in Serum or Plasma | 138 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1897-05-18 | Potassium [Moles/volume] in Serum or Plasma | 4.6 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1897-05-18 | Creatinine [Mass/volume] in Serum or Plasma | 0.9 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 1897-05-18 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1892)/1.73 sq M | 67 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1897-05-18 | Glucose [Mass/volume] in Serum or Plasma | 94 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1897-05-18 | PROMIS sleep related impairment - version 1.0 Tscore | 67 | http://loinc.org · 77859-7 |
| S | 1897-08-17 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1897-08-17 | Potassium [Moles/volume] in Serum or Plasma | 4.5 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1897-08-17 | Creatinine [Mass/volume] in Serum or Plasma | 0.88 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 1897-08-17 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1892)/1.73 sq M | 68 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1897-08-17 | Glucose [Mass/volume] in Serum or Plasma | 93 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1897-08-17 | PROMIS sleep related impairment - version 1.0 Tscore | 55 | http://loinc.org · 77859-7 |
| S | 1897-08-17 | On how many days in the last 3 months did you have a headache, if headache lasted more than 1 day, count each day [PhenX] | 21 | http://loinc.org · 65380-8 |
| S | 1897-08-17 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | http://loinc.org · 44261-6 |
| S | 1897-09-28 | Sodium [Moles/volume] in Serum or Plasma | 136 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1897-09-28 | Potassium [Moles/volume] in Serum or Plasma | 4.8 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1897-09-28 | Creatinine [Mass/volume] in Serum or Plasma | 1.21 mg/dL (high) Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 1897-09-28 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1892)/1.73 sq M | 47 mL/min/1.73 m² (low) Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1897-09-28 | Glucose [Mass/volume] in Serum or Plasma | 88 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1897-10-13 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1897-10-13 | Potassium [Moles/volume] in Serum or Plasma | 4.4 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1897-10-13 | Creatinine [Mass/volume] in Serum or Plasma | 0.9 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 1897-10-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1892)/1.73 sq M | 67 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1897-10-13 | Glucose [Mass/volume] in Serum or Plasma | 92 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1897-10-13 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 1897-10-13 | Total score [Mini-Cog] | 5 | http://loinc.org · 72233-0 |
| S | 1897-10-13 | Total score [AUDIT-C] | 0 | http://loinc.org · 75626-2 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 1897-04-06 | Body height | 152 cm | 8302-2 | S |
| 1897-04-06 | Body weight | 52 kg | 29463-7 | S |
| 1897-04-06 | Body mass index (BMI) [Ratio] | 22.5 kg/m2 | 39156-5 | S |
| 1897-04-06 | Systolic blood pressure | 146 mm[Hg] | 8480-6 | S |
| 1897-04-06 | Diastolic blood pressure | 86 mm[Hg] | 8462-4 | S |
| 1897-04-06 | Heart rate | 72 /min | 8867-4 | S |
| 1897-04-06 | Respiratory rate | 14 /min | 9279-1 | S |
| 1897-04-06 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1897-04-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1897-04-20 | Body height | 152 cm | 8302-2 | S |
| 1897-04-20 | Body weight | 52 kg | 29463-7 | S |
| 1897-04-20 | Body mass index (BMI) [Ratio] | 22.5 kg/m2 | 39156-5 | S |
| 1897-04-20 | Systolic blood pressure | 140 mm[Hg] | 8480-6 | S |
| 1897-04-20 | Diastolic blood pressure | 84 mm[Hg] | 8462-4 | S |
| 1897-04-20 | Heart rate | 70 /min | 8867-4 | S |
| 1897-04-20 | Respiratory rate | 14 /min | 9279-1 | S |
| 1897-04-20 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1897-04-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1897-05-18 | Body height | 152 cm | 8302-2 | S |
| 1897-05-18 | Body weight | 51.5 kg | 29463-7 | S |
| 1897-05-18 | Body mass index (BMI) [Ratio] | 22.3 kg/m2 | 39156-5 | S |
| 1897-05-18 | Systolic blood pressure | 132 mm[Hg] | 8480-6 | S |
| 1897-05-18 | Diastolic blood pressure | 80 mm[Hg] | 8462-4 | S |
| 1897-05-18 | Heart rate | 72 /min | 8867-4 | S |
| 1897-05-18 | Respiratory rate | 14 /min | 9279-1 | S |
| 1897-05-18 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1897-05-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1897-08-17 | Body height | 152 cm | 8302-2 | S |
| 1897-08-17 | Body weight | 51.5 kg | 29463-7 | S |
| 1897-08-17 | Body mass index (BMI) [Ratio] | 22.3 kg/m2 | 39156-5 | S |
| 1897-08-17 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 1897-08-17 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1897-08-17 | Heart rate | 76 /min | 8867-4 | S |
| 1897-08-17 | Respiratory rate | 14 /min | 9279-1 | S |
| 1897-08-17 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1897-08-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1897-09-28 | Body height | 152 cm | 8302-2 | S |
| 1897-09-28 | Body weight | 50.7 kg | 29463-7 | S |
| 1897-09-28 | Body mass index (BMI) [Ratio] | 21.9 kg/m2 | 39156-5 | S |
| 1897-09-28 | Systolic blood pressure | 112 mm[Hg] | 8480-6 | S |
| 1897-09-28 | Diastolic blood pressure | 68 mm[Hg] | 8462-4 | S |
| 1897-09-28 | Heart rate | 90 /min | 8867-4 | S |
| 1897-09-28 | Respiratory rate | 16 /min | 9279-1 | S |
| 1897-09-28 | Body temperature | 37.4 Cel | 8310-5 | S |
| 1897-09-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1897-10-13 | Body height | 152 cm | 8302-2 | S |
| 1897-10-13 | Body weight | 51.2 kg | 29463-7 | S |
| 1897-10-13 | Body mass index (BMI) [Ratio] | 22.2 kg/m2 | 39156-5 | S |
| 1897-10-13 | Systolic blood pressure | 126 mm[Hg] | 8480-6 | S |
| 1897-10-13 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 1897-10-13 | Heart rate | 74 /min | 8867-4 | S |
| 1897-10-13 | Respiratory rate | 14 /min | 9279-1 | S |
| 1897-10-13 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1897-10-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Retired; runs a busy household with relatives and boarders and is active in her church and community
- S No tobacco or alcohol use; does not drive
- S Lived through severe violence and family separation in childhood; prefers to discuss it only as it bears on her care
- S Supports: extended family, her church, and a wide circle of friends
Functional status
- S Independent in all activities of daily living; falls asleep without warning several times a day, including mid-conversation and at meetings
- S Headaches stop household work about two days a week at intake
Mental status
- S Alert between episodes, oriented, and direct; resumes conversation where she left off after a spell; MoCA 26
- S Mood steady; PHQ-9, GAD-7, and PC-PTSD-5 below their thresholds
Allergies and medications
Allergies
- S No known allergy
Medications
- S Ibuprofen 200 mg oral tablet, two tablets by mouth most days (self-directed, over the counter)
- S Acetaminophen 500 mg oral tablet, two tablets by mouth as needed for headache, no more than 2 days a week
- S Candesartan 8 mg oral tablet, one tablet by mouth daily
- S Candesartan 16 mg oral tablet, one tablet by mouth daily
- S Modafinil 100 mg oral tablet, one tablet by mouth each morning
Procedures and immunizations
Procedures
- S Routine EEG: normal background with intermittent left frontal slowing; no epileptiform discharges
- S MRI of the brain: old depressed left frontal skull defect with small underlying encephalomalacia; normal hippocampi; no tumor or other lesion
- S Ambulatory EEG with video, 72 hours: four typical spells captured, each at sleep onset with no ictal pattern
- S Overnight polysomnography: apnea-hypopnea index 4 per hour; no periodic limb movements; REM sleep within 15 minutes of sleep onset
- S Multiple sleep latency test: mean sleep latency 4.5 minutes with two sleep-onset REM periods in five naps
Immunizations
- S 1896-10-13: High-dose influenza vaccine, 1896-1897 season
- S 1897-04-06: Pneumococcal conjugate vaccine PCV20
- S 1894-02-06: Recombinant zoster vaccine, two-dose series completed
- S 1892-08-16: Tdap vaccine
- S 1897-10-13: High-dose influenza vaccine, 1897-1898 season
- S 1897-10-13: RSV vaccine, adjuvanted, single dose
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D Mid-1830s, at about age 13: Head injury in her early teens from an iron weight thrown by an overseer; nearly killed, with little or no medical care (CLM-0003)
- D From the mid-1830s onward: Headaches and sudden spells of sleep with vivid dreams and visions since the injury, continuing into old age (CLM-0004)
- R Retrospective proposal: Temporal lobe epilepsy proposed retrospectively as the cause of the spells; not established (CLM-0005)
- R Retrospective proposal, 2023: Post-traumatic narcolepsy proposed retrospectively in 2023 as an alternative explanation; not established (CLM-0006)
Family history
No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Stop daily over-the-counter analgesics and limit acute headache medicine to no more than 2 days a week | 1897-05-18 | completed | No ibuprofen since the first visit; acetaminophen about once a week |
| Cut headache days by at least half by the three-month review | 1897-08-17 | completed | Headache days fell from 54 to 21 in three months |
| Reduce daytime sleep attacks and lower the PROMIS sleep-related impairment T-score below 60 | 1897-08-17 | completed | T-score fell from 68 to 55; one or two planned naps a day and rare unplanned episodes |
| Establish whether the spells are epileptic before considering antiseizure medicine | 1897-05-18 | completed | Typical spells captured on ambulatory EEG were sleep onset; no antiseizure medicine needed |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Neurology referral for lifelong spells after a head injury, to decide whether they are seizures or sleep attacks | completed | GL-AAN-SEIZURE-2015 |
| Obtain a routine EEG and brain MRI, then capture typical spells on ambulatory EEG with video; start antiseizure medicine only if the spells prove epileptic | completed | GL-AAN-SEIZURE-2015 |
| Overnight polysomnography followed by a multiple sleep latency test to evaluate excessive daytime sleepiness | completed | GL-AASM-HYPERSOMNOLENCE-2021 |
| Start modafinil 100 mg each morning with two scheduled 15-minute naps a day; check blood pressure and heart rate at follow-up | completed | GL-AASM-HYPERSOMNOLENCE-2021 |
| Stop daily ibuprofen, limit acute treatment to 2 days a week, and keep a headache diary | completed | GL-ICHD3-2018, GL-AHS-2021 |
| Start non-sedating headache prevention with candesartan, titrated after a potassium and creatinine check | completed | GL-AHS-2021 |
| Screen mood, anxiety, trauma symptoms, and cognition at baseline with a trauma-informed approach, and repeat the PHQ-9 at follow-up | completed | GL-AAN-SEIZURE-2015, GL-AASM-HYPERSOMNOLENCE-2021 |
Planned encounters
- 1897-04-06 — Primary care visit for lifelong headaches and sudden sleep spells (ENC-001)
- 1897-04-20 — Neurology consultation with EEG and brain MRI (ENC-002)
- 1897-05-18 — Review of ambulatory EEG and sleep studies; four-week headache check (ENC-003)
- 1897-08-17 — Three-month sleepiness and headache review (ENC-004)
- 1897-09-28 — Same-day sick visit for vomiting and diarrhea (ENC-005, unscheduled)
- 1897-10-13 — Subsequent annual wellness visit (ENC-006)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Focused Visit (Care-plan review)
- Progress note 05 — Sick Visit
- Progress note 06 — Annual Wellness Visit, Subsequent
- Neurology referral
- Neurology consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Focused Visit (Care-plan review) (XML)
- Progress note 05 — Sick Visit (XML)
- Progress note 06 — Annual Wellness Visit, Subsequent (XML)
- Neurology referral (XML)
- Neurology consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | The Life of Harriet Tubman (Harriet Tubman Underground Railroad Byway fact sheet) | U.S. National Park Service, Harriet Tubman Underground Railroad National Historical Park | government |
| SRC-0002 | Harriet Ross Tubman Davis (b. circa 1822 - d. 1913), Biographical Series | Maryland State Archives | government |
| SRC-0003 | Thomas O. Ross, Araminta (Harriet Tubman). Dictionary of Canadian Biography, vol. 14 | University of Toronto and Université Laval | biography |
| SRC-0004 | Balmuth EA, Scammell TE. Harriet Tubman's Hypersomnia: Insights from Historical and Medical Perspectives. J Gen Intern Med. 2023;38(16):3621-3627 | Journal of General Internal Medicine (PMC10713879, PubMed 37740167) | scholarly |
| SRC-0005 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the provisional narcolepsy diagnosis after brain injury in an older adult, modafinil dosing, and candesartan as headache prevention. |
| provenance review | not_started | NPS fact sheet, Maryland State Archives, Dictionary of Canadian Biography, and the 2023 JGIM review logged; the Boston surgery is known only from her own account; no birth record exists. |
| safe messaging review | not_started | Childhood violence under slavery is described factually and without graphic detail; trauma screening is negative; death recorded without graphic detail. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.